IGM Thinks Outside Oncology Box With Anti-Infective, Autoimmune Play

The company created two new divisions focused on the new disease areas, bringing in former executives from Bristol Myers Squibb and Sanofi Pasteur.

A professional businessman thinking while standing on a black arrow pointing forward in grey space concept
IGM is expanding its development efforts beyond oncology with new units focused on autoimmune and infectious disease • Source: Shutterstock

More from Anti-infective

More from Therapy Areas